Elizabeth Cho-Fertikh
Gründer bei Meda Angels LLC
Profil
Elizabeth Cho-Fertikh is the founder.
She founded MEDA Angels LLC in 2019, where she holds the title of General Partner & Managing Director.
Currently, Dr. Cho-Fertikh is an Advisor at the National Cancer Institute since 2020 and an Advisor at Enterin, Inc. since 2020.
Dr. Cho-Fertikh previously worked as a Director at VLP Therapeutics LLC from 2016 to 2021.
In terms of education, Dr. Cho-Fertikh holds a doctorate degree from Thomas Jefferson University, an undergraduate degree from The Johns Hopkins University, and a graduate degree from Georgetown University.
Aktive Positionen von Elizabeth Cho-Fertikh
| Unternehmen | Position | Beginn |
|---|---|---|
Meda Angels LLC
 Meda Angels LLC Investment ManagersFinance MEDA Angels LLC (MEDA Angels) is a venture capital firm founded in 2019 by Elizabeth Cho-Fertikh, Amir Rafii, Mark J. Libassi and Ferdinand Hui. The firm is headquartered in Arlington, Virginia. | Gründer | 01.03.2019 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Berater | 01.03.2020 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Berater | 01.04.2020 |
Ehemalige bekannte Positionen von Elizabeth Cho-Fertikh
| Unternehmen | Position | Ende |
|---|---|---|
VLP Therapeutics LLC
 VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | 01.01.2021 |
Ausbildung von Elizabeth Cho-Fertikh
| Thomas Jefferson University | Doctorate Degree |
| Georgetown University | Graduate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Meda Angels LLC
Meda Angels LLC Investment ManagersFinance MEDA Angels LLC (MEDA Angels) is a venture capital firm founded in 2019 by Elizabeth Cho-Fertikh, Amir Rafii, Mark J. Libassi and Ferdinand Hui. The firm is headquartered in Arlington, Virginia. | Finance |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Commercial Services |
